About SteadyMed
SteadyMed is a company based in Rehovot (Israel) founded in 2005 was acquired by United Therapeutics in August 2018.. SteadyMed has raised $44.2 million across 6 funding rounds from investors including United Therapeutics, Orbimed and Federated Hermes. SteadyMed operates in a competitive market with competitors including Ensysce, Oxular, Arecor, pSivida and EryDel, among others.
- Headquarter Rehovot, Israel
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$44.2 M (USD)
in 6 rounds
-
Latest Funding Round
$30 M (USD), Post-IPO
Apr 23, 2017
-
Investors
United Therapeutics
& 9 more
-
Employee Count
Employee Count
-
Acquired by
United Therapeutics
(Aug 30, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of SteadyMed
SteadyMed has successfully raised a total of $44.2M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $30 million completed in April 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $30.0M
-
First Round
First Round
(28 Jan 2009)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2017 | Amount | Post-IPO - SteadyMed | Valuation |
investors |
|
| Aug, 2016 | Amount | Post-IPO - SteadyMed | Valuation |
investors |
|
| Jan, 2015 | Amount | Series C - SteadyMed | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SteadyMed
SteadyMed has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include United Therapeutics, Orbimed and Federated Hermes. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Tech & Life Sciences focused VC firm investing in early stage startups in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SteadyMed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SteadyMed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Steadymed Comparisons
Competitors of SteadyMed
SteadyMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ensysce, Oxular, Arecor, pSivida and EryDel, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug delivery solutions via single-walled carbon nanotubes are offered.
|
|
| domain | founded_year | HQ Location |
Drug delivery platforms and therapeutics for ophthalmology are developed.
|
|
| domain | founded_year | HQ Location |
Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery
|
|
| domain | founded_year | HQ Location |
Drug delivery systems
|
|
| domain | founded_year | HQ Location |
Erythrocyte encapsulation systems for drug delivery are developed.
|
|
| domain | founded_year | HQ Location |
Provider of needle-free injection technology
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Steadymed
Frequently Asked Questions about SteadyMed
When was SteadyMed founded?
SteadyMed was founded in 2005 and raised its 1st funding round 4 years after it was founded.
Where is SteadyMed located?
SteadyMed is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
Is SteadyMed a funded company?
SteadyMed is a funded company, having raised a total of $44.2M across 6 funding rounds to date. The company's 1st funding round was a Series C of $12.2M, raised on Jan 28, 2009.
What does SteadyMed do?
SteadyMed was founded in 2005 in Rehovot, Israel, as a medical-device company focused on technology for delivering high-volume small molecule or biologic drugs exceeding 2 ml. Specialty pharmaceutical products, including drug-device combinations, are developed primarily for pulmonary arterial hypertension and at-home analgesia applications. Technology licensing serves as a secondary operation. Products await FDA approval, with the company having gone public in March 2015.
Who are the top competitors of SteadyMed?
SteadyMed's top competitors include Oxular, PharmaJet and Splice Bio.
Who are SteadyMed's investors?
SteadyMed has 10 investors. Key investors include United Therapeutics, Orbimed, Federated Hermes, Adage Capital Management, and Deerfield Management Group.